GRIA2 and Alzheimer disease: Changes in the efficiency of editing at the Q/R site of GluA2 have been reported in several human AD brain regions including the prefrontal cortex [51], temporal lobe [21] and hippocampus [50, 52], strongly suggesting the proportion of AMPARs containing unedited GluA2(Q) are increased in AD.